Minimal Change Disease: Clinical Trials

2 trials for Minimal Change Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow Minimal Change Disease: new trials by email Literature Review of Minimal Change Disease trials Research Report on Minimal Change Disease

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Active Vitamin D And Reduced Dose Prednisolone for Treatment in Minimal Change Nephropathy
Prednisolone, Alfacalcidol - Minimal Change Disease, Nephrotic Syndrome
Phase 4CompletedUniversity of Aarhus712018-05-012025-01-24
Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease
tacrolimus, prednisolone - Minimal Change Disease
Phase 4CompletedImperial College Healthcare NHS Trust522009-12-012021-05-04

Narrower conditions

Nephrosis, Lipoid (2)  ·  Nephrotic Syndrome (1)

Broader conditions

Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Nephrosis (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)

Interventions

Prednisolone (2)  ·  Prednisone (1)  ·  Tacrolimus (1)  ·  alfacalcidol (1)

Sponsors

Imperial College Healthcare NHS Trust (1)  ·  University of Aarhus (1)

Countries

Denmark (1)  ·  United Kingdom (1)

Top investigators

Megan Griffith, MBChBPhDFRCP (1)  ·  Per Ivarsen (1)  ·  Tom Cairns, MBBSMRCP (1)

Results publications

PMID 35230699, PMID 34247632, PMID 41905593

NIH funding

2009 (1)